|
gptkbp:instanceOf
|
nerve agent
|
|
gptkbp:antidote
|
gptkb:pralidoxime
atropine
|
|
gptkbp:aroma
|
colorless, odorless
|
|
gptkbp:bannedIn
|
gptkb:international_relations
|
|
gptkbp:boilingPoint
|
158°C
|
|
gptkbp:CASNumber
|
107-44-8
|
|
gptkbp:category
|
gptkb:Dragon
organophosphate
chemical warfare agent
|
|
gptkbp:chemicalFormula
|
C4H10FO2P
|
|
gptkbp:degradation_product
|
gptkb:isopropyl_methylphosphonic_acid
|
|
gptkbp:density
|
1.09 g/cm³
|
|
gptkbp:discoveredBy
|
German scientists
|
|
gptkbp:discoveredIn
|
1938
|
|
gptkbp:effect
|
death
respiratory failure
convulsions
|
|
gptkbp:firstSynthesized
|
gptkb:Germany
|
|
gptkbp:hazard_class
|
Acute Toxicity (Dermal) Category 1
Acute Toxicity (Inhalation) Category 1
Acute Toxicity (Oral) Category 1
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
GB (Sarin) nerve agent
|
|
gptkbp:IUPACName
|
gptkb:Isopropyl_methylphosphonofluoridate
|
|
gptkbp:mechanismOfAction
|
gptkb:acetylcholinesterase_inhibitor
|
|
gptkbp:meltingPoint
|
-56°C
|
|
gptkbp:militaryDesignation
|
gptkb:GB
|
|
gptkbp:molecularWeight
|
140.1 g/mol
|
|
gptkbp:physical_state
|
liquid at room temperature
|
|
gptkbp:prohibits
|
gptkb:Chemical_Weapons_Convention
|
|
gptkbp:relatedTo
|
gptkb:VX_nerve_agent
gptkb:Soman
gptkb:Tabun
|
|
gptkbp:routeOfExposure
|
inhalation
ingestion
skin absorption
|
|
gptkbp:solubility
|
miscible
|
|
gptkbp:storage_requirement
|
airtight containers
|
|
gptkbp:symptom
|
salivation
muscle twitching
seizures
miosis
|
|
gptkbp:toxicity
|
highly toxic
|
|
gptkbp:UNNumber
|
2810
|
|
gptkbp:used_in
|
gptkb:Syrian_Civil_War
gptkb:military_organization
gptkb:Tokyo_subway_attack
|
|
gptkbp:usedFor
|
chemical weapon
|
|
gptkbp:bfsParent
|
gptkb:Anniston_Chemical_Activity
gptkb:Chemical_Stockpile_Elimination_Program
|
|
gptkbp:bfsLayer
|
8
|